Neuroimaging Studies of the Treatment of Bipolar Depression With Citalopram

Completed

Conditions studied: Bipolar Depression

In brief

Regional metabolic changes associated with response to 6 weeks of citalopram treatment, using 18-Fluorodeoxyglucose Positron Emission Tomography imaging, will be characterized (FDG PET).

Key facts

Study ID

NCT01639482

Run by

Massachusetts General Hospital

People needed

60

Starts

2010-04-01

Expected to finish

2013-12-01

Last updated by the study team

2019-03-07

Who can join

Age: 18 and older, up to 64. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Current age 18-64 years; DSM-IV diagnosis of BPD, type-I, or type-II; Enrolled in the Citalopram Study at Tufts Medical Center

You may not qualify if…

• Current pregnancy, or inability to utilize contraception, The presence of any metallic implants, History of claustrophobia

Where it is running

• Massachusetts General Hospital - East — Charlestown, Massachusetts, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.